| Product Code: ETC10176298 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Precision Pathology Cancer Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Precision Pathology Cancer Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Precision Pathology Cancer Market - Industry Life Cycle |
3.4 South Korea Precision Pathology Cancer Market - Porter's Five Forces |
3.5 South Korea Precision Pathology Cancer Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.6 South Korea Precision Pathology Cancer Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 South Korea Precision Pathology Cancer Market Revenues & Volume Share, By Technology Used, 2021 & 2031F |
3.8 South Korea Precision Pathology Cancer Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
4 South Korea Precision Pathology Cancer Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in South Korea |
4.2.2 Advancements in precision pathology technologies |
4.2.3 Growing demand for personalized medicine in cancer treatment |
4.3 Market Restraints |
4.3.1 High costs associated with precision pathology testing |
4.3.2 Limited access to advanced healthcare services in certain regions of South Korea |
5 South Korea Precision Pathology Cancer Market Trends |
6 South Korea Precision Pathology Cancer Market, By Types |
6.1 South Korea Precision Pathology Cancer Market, By Test Type |
6.1.1 Overview and Analysis |
6.1.2 South Korea Precision Pathology Cancer Market Revenues & Volume, By Test Type, 2021 - 2031F |
6.1.3 South Korea Precision Pathology Cancer Market Revenues & Volume, By Biomarker Testing, 2021 - 2031F |
6.1.4 South Korea Precision Pathology Cancer Market Revenues & Volume, By Molecular Testing, 2021 - 2031F |
6.1.5 South Korea Precision Pathology Cancer Market Revenues & Volume, By Next-Generation Sequencing, 2021 - 2031F |
6.1.6 South Korea Precision Pathology Cancer Market Revenues & Volume, By Imaging Techniques, 2021 - 2031F |
6.2 South Korea Precision Pathology Cancer Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 South Korea Precision Pathology Cancer Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.2.3 South Korea Precision Pathology Cancer Market Revenues & Volume, By Lung Cancer, 2021 - 2031F |
6.2.4 South Korea Precision Pathology Cancer Market Revenues & Volume, By Prostate Cancer, 2021 - 2031F |
6.2.5 South Korea Precision Pathology Cancer Market Revenues & Volume, By Colon Cancer, 2021 - 2031F |
6.3 South Korea Precision Pathology Cancer Market, By Technology Used |
6.3.1 Overview and Analysis |
6.3.2 South Korea Precision Pathology Cancer Market Revenues & Volume, By Digital Pathology, 2021 - 2031F |
6.3.3 South Korea Precision Pathology Cancer Market Revenues & Volume, By Immunohistochemistry, 2021 - 2031F |
6.3.4 South Korea Precision Pathology Cancer Market Revenues & Volume, By Whole Slide Imaging, 2021 - 2031F |
6.3.5 South Korea Precision Pathology Cancer Market Revenues & Volume, By Fluorescent In Situ Hybridization, 2021 - 2031F |
6.4 South Korea Precision Pathology Cancer Market, By Service Type |
6.4.1 Overview and Analysis |
6.4.2 South Korea Precision Pathology Cancer Market Revenues & Volume, By Diagnostic Services, 2021 - 2031F |
6.4.3 South Korea Precision Pathology Cancer Market Revenues & Volume, By Laboratory Services, 2021 - 2031F |
6.4.4 South Korea Precision Pathology Cancer Market Revenues & Volume, By In-House Testing, 2021 - 2031F |
6.4.5 South Korea Precision Pathology Cancer Market Revenues & Volume, By Third-Party Testing, 2021 - 2031F |
7 South Korea Precision Pathology Cancer Market Import-Export Trade Statistics |
7.1 South Korea Precision Pathology Cancer Market Export to Major Countries |
7.2 South Korea Precision Pathology Cancer Market Imports from Major Countries |
8 South Korea Precision Pathology Cancer Market Key Performance Indicators |
8.1 Adoption rate of precision pathology technologies in cancer diagnosis |
8.2 Number of precision pathology tests conducted annually |
8.3 Rate of incorporation of personalized medicine in cancer treatment plans |
9 South Korea Precision Pathology Cancer Market - Opportunity Assessment |
9.1 South Korea Precision Pathology Cancer Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.2 South Korea Precision Pathology Cancer Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 South Korea Precision Pathology Cancer Market Opportunity Assessment, By Technology Used, 2021 & 2031F |
9.4 South Korea Precision Pathology Cancer Market Opportunity Assessment, By Service Type, 2021 & 2031F |
10 South Korea Precision Pathology Cancer Market - Competitive Landscape |
10.1 South Korea Precision Pathology Cancer Market Revenue Share, By Companies, 2024 |
10.2 South Korea Precision Pathology Cancer Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here